Overview of new approaches for the management of patients with lung cancer presented at ESMO 2024.

Overview of the treatment options for treatment naive (TN) and relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and the use of BTKis in indolent lymphomas presented at the EHA2024 Hybrid Congress.

Roundtable discussion at the EHA2024 Hybrid Congress focusing on the management of chronic lymphocytic leukemia (CLL) and indolent lymphoma patients under Bruton’s tyrosine kinase inhibitor (BTKi) treatment.

Overview of the treatment landscape and management options for patients with oesophageal squamous cell carcinoma (ESCC) and gastric/gastro-oesophageal junction adenocarcinoma (GC/GEJC) presented at the ESMO Gastrointestinal Cancers Congress 2024. Watch the recording below.

Discussion on mental health and the psychological impact of chronic lymphocytic leukemia (CLL) therapy considering patient and physician perspectives at the 14^th International Workshop of the GCLLSG.